slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,557
Current window 39,271-39,300
Pages 2,019
Rows per page 30
Component
39,271-39,300 of 60,557
43
The slide uses a hub-and-spoke visual to connect the total capital generation to specific allocation buckets.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
51
Standard financial disclosure slide for public company reporting.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
53
Standard financial disclosure table.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
54
The table provides a breakdown of specific liability adjustments to arrive at a non-GAAP measure.Apollo Global Management | Investor Presentation Deck | 60 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
10
Includes non-GAAP financial measure disclaimer.AppHarvest | Results Presentation Deck | 13 slides · AppHarvest
Conference presentation Investor relations 1 hit
12
The slide provides a standard non-GAAP financial reconciliation for AppHarvest.AppHarvest | Results Presentation Deck | 13 slides · AppHarvest
Conference presentation Investor relations 1 hit
11
Data presented at EASL 2022 and AASLD 2022.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
19
The slide details a specific licensing deal, including financial terms and partner background.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
25
The slide maps the viral genome to specific drug targets and highlights partnerships with X-Chem and Proteros.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
27
The slide uses a table to present a timeline of clinical milestones.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
21
The chart uses a horizontal bar format to represent clinical trial stages (Preclinical to Commercial) for multiple indications under four main programs (VYVGART, Efgartigimod, ARGX-117, ARGX-119).argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations 1 hit
07
The slide highlights a total full-year revenue of $401M in the first year of launch.argenx SE | Results Presentation Deck | 11 slides · argenx
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
08
Includes a callout for cash position at year-end.argenx SE | Results Presentation Deck | 11 slides · argenx
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
27
Includes specific footnotes regarding non-cash impairment charges and exchange rate calculations.Arrival | Results Presentation Deck | 28 slides · Arrival
Conference presentation Investor relations Beat · Action1 hit
16
Astra | Results Presentation Deck | 19 slidesAstra | Results Presentation Deck | 19 slides · Astra
Conference presentation Investor relations 1 hit
05
The central diagram is a circular representation of three pillars (Healthy people, Healthy society, Healthy planet) with nine sub-focus areas.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Current StateLoop · Golden Circle1 hit
05
The slide uses a Gantt-style visualization to show the progress of drug development programs.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
09
Includes a quote from Keith Nuechterlein and specific Cohen's d effect size metrics.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
18
The slide uses a split layout: a dark sidebar for product specs and a white main area for clinical data visualization.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
23
The slide uses a numbered list to highlight key safety findings alongside a detailed data table.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
26
The slide uses a checkmark matrix to highlight the competitive advantages of the proposed drug.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
29
The slide uses a line chart to demonstrate reduction in HCQN subscales over time, and a process diagram to outline the ongoing Phase 1/2 trial stages.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
30
The slide uses a feature-comparison matrix to highlight the unique value proposition of DMX-1002 (Ibogaine) against standard MAT and withdrawal support drugs.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
07
The revenue split chart uses a nested donut/sunburst style to show segments.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
24
The slide uses a table-like structure to map strategic pillars to specific achievements.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations 1 hit
27
The slide uses a feature-comparison matrix to differentiate service tiers for publishers.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations 1 hit
06
The slide is partially obscured at the bottom, hiding some text in the table and the second bullet point.Azerion | Results Presentation Deck | 15 slides · Azerion
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
10
The table presents financial data in £'000s. Footnotes clarify exclusions related to Business Combination.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · Financials1 hit
11
The table details specific non-recurring costs related to a Business Combination, including share-based payments and impairment of assets.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · Financials1 hit
12
The slide provides a bridge between operating loss and cash flow, with explanatory notes on the right side.BenevolentAI | Results Presentation Deck | 38 slides · BenevolentAI
Conference presentation Investor relations Beat · Financials1 hit